News release 2020 AMAG Pharmaceuticals Files Submission in Response To the Food And Drug Administration’s Notice of Opportunity for a Hearing and Proposal To Withdraw Approval of Makena® (hydroxyprogesterone caproate injection) December 14, 2020 Covis Group Announces Data for Ciraparantag Published in Blood, the Journal of the American Society of Hematology November 19, 2020 Covis Group Completes Acquisition of AMAG Pharmaceuticals November 16, 2020 Amag Pharmaceuticals requests hearing to maintain Makena® (Hydroxyprogesterone Caproate Injection) as a treatment option for clinically indicated pregnant patients October 14, 2020 AMAG Pharmaceuticals Provides Update on FDA’s Proposal Regarding Makena® (Hydroxyprogesterone Caproate Injection) October 5, 2020 Covis Group Announces Agreement to Acquire AMAG Pharmaceuticals October 1, 2020 Funds Managed by Affiliates of Apollo Global Management to Acquire Covis Pharma From Cerberus February 6, 2020 News release 2022202120202018201720152013
AMAG Pharmaceuticals Files Submission in Response To the Food And Drug Administration’s Notice of Opportunity for a Hearing and Proposal To Withdraw Approval of Makena® (hydroxyprogesterone caproate injection) December 14, 2020
Covis Group Announces Data for Ciraparantag Published in Blood, the Journal of the American Society of Hematology November 19, 2020
Amag Pharmaceuticals requests hearing to maintain Makena® (Hydroxyprogesterone Caproate Injection) as a treatment option for clinically indicated pregnant patients October 14, 2020
AMAG Pharmaceuticals Provides Update on FDA’s Proposal Regarding Makena® (Hydroxyprogesterone Caproate Injection) October 5, 2020
Funds Managed by Affiliates of Apollo Global Management to Acquire Covis Pharma From Cerberus February 6, 2020
